RRC ID 63082
著者 Minagawa Y, Ishino K, Wada R, Kudo M, Naito Z, Takeshita T, Ohashi R.
タイトル High Expression of p21 as a Potential Therapeutic Target in Ovarian Clear-cell Carcinoma.
ジャーナル Anticancer Res
Abstract BACKGROUND/AIM:DNA damage response (DDR), wherein p21 is a cell fate determinant, is a potential cancer therapeutic target. Molecular expression during DDR was explored in ovarian clear-cell carcinoma (CCC).
MATERIALS AND METHODS:CHK1, CHK2, TP53 and p21 expression in DDR was examined using immunostaining in surgical sections of CCC (n=22). Molecular alterations in two types of CCC cell lines, JHOC-5 and JHOC-9, were investigated using western blot analysis.
RESULTS:Expression of DDR-associated molecules was noted in most patients. While high p21 expression was found in half of the patients, the remaining patients exhibited low p21 expression. Treatment with UC2288, a p21 inhibitor, attenuated proliferation of both cell lines, more prominently in JHOC-9, resulting in reduced viability and subsequent apoptosis.
CONCLUSION:p21 Inhibitor induced cell death in cells with high p21 expression, suggesting that p21 suppression can be a therapeutic strategy to treat patients with CCC.
巻・号 40(10)
ページ 5631-5639
公開日 2020-10-1
DOI 10.21873/anticanres.14576
PII 40/10/5631
PMID 32988887
MeSH Adult Aged Apoptosis / genetics Cell Line, Tumor Cell Proliferation / genetics Checkpoint Kinase 1 / genetics* Checkpoint Kinase 2 / genetics* Cyclin-Dependent Kinase Inhibitor p21 / genetics* DNA Damage / genetics Female Gene Expression Regulation, Neoplastic Humans Middle Aged Ovarian Neoplasms / genetics* Ovarian Neoplasms / pathology Tumor Suppressor Protein p53 / genetics*
IF 1.994
リソース情報
ヒト・動物細胞 JHOC-5(RCB1520) JHOC-9(RCB2226)